title: Ovarian preservation with subcutaneous transposition in the setting of cytoreductive surgery.
abstract: BACKGROUND
  In recent years, cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has gained increasing acceptance as a treatment modality for peritoneal carcinomatosis. In female patients, this procedure involves a total hysterectomy and bilateral saphingo-oophorectomy to remove the pelvic peritoneum. We present a case of an unfortunate female adolescent with peritoneal carcinomatosis who underwent cytoreductive surgery and HIPEC. In view of the compelling circumstance, an innovative surgical technique was used to attempt ovarian preservation.
  
  
  METHODS
  A 14 year old girl with carcinoma of the sigmoid colon and peritoneal metastases was offered cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. In view of her age, ovarian preservation with subcutaneous transposition was performed during cytoreductive surgery. She is currently well 6 months post surgery and has resumed normal menstruation. We review the literature regarding ovarian preservation with subcutaneous transposition and discuss its benefit in pre-menopausal women undergoing peritonectomy and cytoreductive surgery for peritoneal carcinomatosis.
  
  
  CONCLUSIONS
  Subcutaneous transposition of the ovary in pre-menopasual patients requiring cytoreductive surgery spares them the sequelae of surgical castration. The subcutaneous location of the transposed ovary conveys advantages such as the ease of ultrasound surveillance and removal in event of disease recurrence. It also retains the possibility of future conception as the transposed ovary can easily be accessed for ovum extraction with assisted reproductive techniques.
  
  
  CONCLUSIONS
  Ovarian preservation with subcutaneous transposition is a technique worth considering in the treatment of pre-menopausal women who require cytoreductive surgery for peritoneal carcinomatosis.
authors: Department of General Surgery, Singapore General Hospital, Singapore.
authors: Winson Jianhong
authors: WJ
authors: Tan
authors: Jingjin
authors: J
authors: Jung
authors: Claramae Shulyn
authors: CS
authors: Chia
authors: Melissa Ching Ching
authors: MC
authors: Teo
authors: Han Chong
authors: HC
authors: Toh
authors: Khee Chee
authors: KC
authors: Soo
references: J Surg Oncol. 2008 Sep 15;98(4):232-6
references: 18726883
references: Ann Acad Med Singap. 2010 Jan;39(1):54-7
references: 20126816
references: J Clin Oncol. 2009 Feb 10;27(5):681-5
references: 19103728
references: Endocrinology. 1999 Jan;140(1):462-71
references: 9886858
references: Lancet Oncol. 2006 Jan;7(1):69-76
references: 16389186
references: Ann Med. 2011;43(6):437-50
references: 21226660
references: Semin Reprod Med. 2011 Jan;29(1):15-23
references: 21207331
references: Am J Obstet Gynecol. 1968 Jul 15;101(6):756-9
references: 5660971
references: Fertil Steril. 2005 Apr;83(4):897-901
references: 15820797
references: Int J Gynaecol Obstet. 1997 Aug;58(2):223-8
references: 9252259
references: Fertil Steril. 2001 Apr;75(4):705-10
references: 11287023
references: Chin Med J (Engl). 2003 May;116(5):688-91
references: 12875681
references: Int J Gynecol Cancer. 2006 Jan-Feb;16(1):121-4
references: 16445621